Resistant TB: Newer Drugs and Community Approach.

@article{Gothi2011ResistantTN,
  title={Resistant TB: Newer Drugs and Community Approach.},
  author={D. Gothi and J. Joshi},
  journal={Recent patents on anti-infective drug discovery},
  year={2011},
  volume={6 1},
  pages={
          27-37
        }
}
  • D. Gothi, J. Joshi
  • Published 2011
  • Medicine
  • Recent patents on anti-infective drug discovery
Drug resistance in tuberculosis (TB) is a serious problem compromising both the treatment and control programs. Poor usage of the available anti TB drugs has led to progressive drug resistance-multi drug resistance (MDR), extensively drug-resistance (XDR) and even total drug resistance (TDR). While drug sensitive TB is completely curable, MDR-TB is difficult to treat, XDR and TDR are often fatal. Non availability of new drugs to treat drug resistant cases further complicates the problem. The… Expand
Drug resistance mechanisms and novel drug targets for tuberculosis therapy.
Bedaquiline and delamanid in tuberculosis
A Virtual Screen Discovers Novel, Fragment-Sized Inhibitors of Mycobacterium tuberculosis InhA
Recent developments in the epidemiology and management of tuberculosis – new solutions to old problems?
Pharmacokinetics of Sequential Doses of Capreomycin Powder for Inhalation in Guinea Pigs
Pretomanid: First Approval
...
1
2
3
...